SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

Agilis NxT

STEERABLE INTRODUCER

Agilis NxT
About

Choose the Gold Standard

As evidenced in more than one million procedures*, for a growing number of physicians, Agilis™ NxT Steerable Introducer is the introducer of choice when guiding ablation catheters to treat arrhythmias. Tailor to your patient’s anatomy with a large variety of sizes & curves that maintain their shape.

Curve sizes for the Agilis NxT Steerable Introducer

 

Confident steering and stable positioning with exceptional maneuverability

Enhanced catheter stability enables control of tip movements within millimeters along the intended ablation line1

Access hard-to-reach areas with precise maneuverability and auto-lock steering, such as the right inferior and left anterior pulmonary veins1

 

Enhanced procedural efficiency with exceptional contact force

60%

 

 

Greater catheter-tissue contact force, which may support more durable lesion formation2

 

 

Higher left atrial wall contact, and more efficient energy delivery, especially critical for thicker left atrial musculature1

Experience Greater Agility and Stability

The Agilis NxT steerable introducer combines a low profile with high-tech capabilities, giving you greater control during electrophysiology (EP) procedures.3

Indicated for introducing various cardiovascular catheters into the heart, the steerable sheath improves access to hard-to-reach sites (including the left side of the heart through the interatrial septum), eliminating the need to change out sheaths in order to reach the desired position.4

 

Key Features
 

  • Multiple curve choices, including small (16.8 mm), medium (22.4 mm) and large (50.0 mm) curl options
  • Low-profile outer diameter and a large 8.5 F inner lumen, to facilitate passage of a wide variety of catheters
  • Dual-Reach™ bi-directional 180˚/90˚ deflection to allow asymmetric deflection for more mobility with less shaft torque
  • Auto-lock capability to reduce curve movements during complex procedures5
  • Braided shaft provides exceptional torqueability, pushability and kink resistance
  • Radiopaque tip marker enhances fluoro visibility
  • Ultimum™ hemostasis valve provides effective hemostasis, and seals down to a 0.014 inch guidewire
  • Accommodates a 98 cm BRK™ transseptal needle and BRK-1™ transseptal needle
  • Ergonomic handle provides user comfort
  • Improved kink resistance for difficult or long procedures (G4083xx models)

 

Greater freedom from arrhythmia at 6 months (76.0% vs 53.0%)3 and 18% greater at 12 months (74.0% vs 62.7%)4

 

Complete PVI isolation (left- and right-sided veins) (43 pts vs 8 pts)1

 

Fewer re-do ablations (6 pts vs 23 pts)1 and 17% fewer acute PV reconnections (50% vs 60%)5

Manuals & Resources

Manuals & Resources

Customer Service

Customer Service

This device is commercially available for use in select international markets.

BOLD SOLUTIONS
TO CHALLENGE AFIB

Learn More
Bold Solutions to challenge AFIB
Bold Solutions to challenge AFIB
Manuals & Resources

Manuals & Resources

Cardiovascular Products

Cardiovascular Products

Customer Service

Customer Service

*Based on sales through Dec 31, 2020

References

  1. Piorkowski C, et al. (2008). Steerable sheath catheter navigation for ablation of atrial fibrillation: A case-control study. Pacing and Clinical Electrophysiology, 31(7), 863–873.
  2. Cuoco F, et al. (2014). Steerable sheath promotes improved contact force parameters during pulmonary vein isolation. Heart Rhythm, Vol. 11, No. 5, May Supplement.
  3. Piorkowski C, et al. (2011). Steerable versus non-steerable sheath technology in AF ablation: A prospective, randomized study. Circulation, 4(2), 157–165.
  4. Mansour M. (2014). TOCCASTAR: Preliminary Results of the First Prospective Randomized Study of a Contact Force Sensing Ablation Catheter for the Treatment of Paroxysmal AF. Presented at HRS AF Summit 2014. San Francisco, California.
  5. Hutchinson M, et al. (2013). Efforts to enhance catheter stability improve atrial fibrillation ablation outcome. Heart Rhythm, 10(3), 347–353.

MAT-2101186 v1.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0